Literature DB >> 1348364

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

A K Godwin1, A Meister, P J O'Dwyer, C S Huang, T C Hamilton, M E Anderson.   

Abstract

Exposure of human ovarian tumor cell lines to cisplatin led to development of cell lines that exhibited increasing degrees of drug resistance, which were closely correlated with increase of the levels of cellular glutathione. Cell lines were obtained that showed 30- to 1000-fold increases in resistance; these cells also had strikingly increased (13- to 50-fold) levels of glutathione as compared with the drug-sensitive cells of origin. These levels of resistance to cisplatin and the cellular glutathione levels are substantially greater than previously reported. Very high cisplatin resistance was associated with enhanced expression of mRNAs for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase; immunoblots showed increase of gamma-glutamylcysteine synthetase but not of glutathione synthetase. Glutathione S-transferase activity was unaffected, as determined with chlorodinitrobenzene as a substrate. These studies suggest the potential value of examining regulation of glutathione synthesis as an indicator of clinical prognosis. The highly resistant cell lines are proving useful for studying the multiple mechanisms by which tumor cells acquire drug- and radiation-resistance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348364      PMCID: PMC48805          DOI: 10.1073/pnas.89.7.3070

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  CARCINOGENIC AZO DYES, DYE-BINDING AND LIVER GLUTATHIONE.

Authors:  W J NEISH; H M DAVIES; P M REEVE
Journal:  Biochem Pharmacol       Date:  1964-09       Impact factor: 5.858

2.  Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.

Authors:  P J O'Dwyer; T C Hamilton; R C Young; F P LaCreta; N Carp; K D Tew; K Padavic; R L Comis; R F Ozols
Journal:  J Natl Cancer Inst       Date:  1992-02-19       Impact factor: 13.506

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: possible chemotherapeutic implications.

Authors:  A Meister; O W Griffith
Journal:  Cancer Treat Rep       Date:  1979-06

5.  gamma-Glutamyl transpeptidase and malignant transformation of cultured liver cells.

Authors:  E Huberman; R Montesano; C Drevon; T Kuroki; L St Vincent; T D Pugh; S Goldfarb
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

6.  Inhibition of glutathione biosynthesis by prothionine sulfoximine (S-n-propyl homocysteine sulfoximine), a selective inhibitor of gamma-glutamylcysteine synthetase.

Authors:  O W Griffith; M E Anderson; A Meister
Journal:  J Biol Chem       Date:  1979-02-25       Impact factor: 5.157

7.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

8.  Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis.

Authors:  S Fiala; A Mohindru; W G Kettering; A E Fiala; H P Morris
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

9.  Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione.

Authors:  P G Richman; A Meister
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

Review 10.  Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy.

Authors:  A Meister
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

View more
  234 in total

1.  Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum.

Authors:  K Ikeda; K Miura; S Himeno; N Imura; A Naganuma
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101.

Authors:  Wenbin Hu; Fang Wang; Jingsheng Tang; Xinyu Liu; Zhu Yuan; Chunlai Nie; Yuquan Wei
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

3.  Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.

Authors:  Kalpana Mujoo; Masayuki Watanabe; Junichi Nakamura; Abdul R Khokhar; Zahid H Siddik
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-26       Impact factor: 4.553

4.  Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.

Authors:  Xiang Ling; Jiasheng Tu; Junqing Wang; Aram Shajii; Na Kong; Chan Feng; Ye Zhang; Mikyung Yu; Tian Xie; Zameer Bharwani; Bader M Aljaeid; Bingyang Shi; Wei Tao; Omid C Farokhzad
Journal:  ACS Nano       Date:  2018-12-04       Impact factor: 15.881

5.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator.

Authors:  Shaoyu Wang; Vincent J Higgins; Janice R Aldrich-Wright; Ming J Wu
Journal:  J Chem Biol       Date:  2011-12-06

7.  Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.

Authors:  Christina Peklak-Scott; Pamela K Smitherman; Alan J Townsend; Charles S Morrow
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

8.  Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.

Authors:  Xiang Ling; Xing Chen; Imogen A Riddell; Wei Tao; Junqing Wang; Geoffrey Hollett; Stephen J Lippard; Omid C Farokhzad; Jinjun Shi; Jun Wu
Journal:  Nano Lett       Date:  2018-06-19       Impact factor: 11.189

9.  Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.

Authors:  Fernanda Musa; Amandine Alard; Gizelka David-West; John P Curtin; Stephanie V Blank; Robert J Schneider
Journal:  Mol Cancer Ther       Date:  2016-05-16       Impact factor: 6.261

10.  Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.

Authors:  Lixu Jin; Yi Huo; Zhiguo Zheng; Xiaoyong Jiang; Haiyun Deng; Yuling Chen; Qingquan Lian; Renshan Ge; Haiteng Deng
Journal:  Mol Cell Proteomics       Date:  2014-08-05       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.